Bronchoalveolar lavage: A key tool in pulmonary fungal infection management
Turkish Journal of Pediatric Disease · 23.03.2026 · 1-5
DOI: 10.12956/tjpd.2026.1255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Pediatric Disease, online erschienen am 23.03.2026. Verfasst von Hande Yetişgin und 14 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Bronchoalveolar lavage (BAL) is a widely used diagnostic tool for evaluating lower respiratory tract infections and pulmonary pathologies in children. BAL provides valuable diagnostic information and can significantly influence management strategies, particularly in patients with malignancy, immunodeficiency (ID), or critical illness. This study aimed to assess the diagnostic and therapeutic value of BAL in pulmonary fungal infections. Material and Methods: This retrospective study analyzed BAL samples obtained by flexible fiberoptic bronchoscopy (FFB) between 2019 and 2024 in the Pediatric Pulmonology Department of a tertiary referral center. Among 668 patients who underwent FFB, those with BAL fungal culture, BAL Aspergillus DNA PCR, and BAL galactomannan antigen (GM) testing were included. Demographic, clinical, radiological, and bronchoscopic findings, as well as antifungal treatment modifications based on BAL results, were evaluated.
Results
BAL results from 668 patients were reviewed. Fungal culture was performed in 236 (35.3%), Aspergillus DNA PCR in 127 (19%), and GM in 121 (18.1%) patients. Among those tested for fungal culture, 58.9% were male, with a mean age of 7.0 years (±5.7). Fungal culture positivity was found in 26 (11%) patients: Candidaalbicans (n=14), Aspergillus spp. (n=5), Candidadubliniensis (n=3), Aspergillus fumigatus (n=3), and Penicillium spp. (n=1). Culture positivity was significantly higher in patients with malignancy (p=0.011). BAL Aspergillus DNA PCR was positive in two patients, and BAL GM in five. Based on BAL results, antifungal therapy was modified in seven patients.
Conclusion
BAL fungal culture, BAL GM, and Aspergillus PCR testing are valuable diagnostic tools for pulmonary fungal infections in children, especially those with malignancy or immunodeficiency (ID). The observed treatment modifications following BAL results emphasize their clinical importance not only in establishing diagnosis but also in guiding and optimizing antifungal therapy.
Zitieren
APA
Yetişgin, H., Uytun, S., Gençoğlu, M. Y., Soydaş, Ş. S. A., Tabakçı, S. Ö., Bilgiç, I., Çakar, M. K., Dinç, G. A., Ünlü, A., Tokdemir, B. E., Yıldırım, Ç., Tuğcu, G. D., Tural, D. A., Polat, S. E., & Cinel, G. (2026). Bronchoalveolar lavage: A key tool in pulmonary fungal infection management. Turkish Journal of Pediatric Disease, 1-5. https://doi.org/10.12956/tjpd.2026.1255
Vancouver
Yetişgin H, Uytun S, Gençoğlu MY, Soydaş ŞSA, Tabakçı SÖ, Bilgiç I, et al. Bronchoalveolar lavage: A key tool in pulmonary fungal infection management. Turkish Journal of Pediatric Disease. 2026:1-5. doi:10.12956/tjpd.2026.1255
BibTeX
@article{Yetigin2026,
author = {Yetişgin, Hande and Uytun, Salih and Gençoğlu, Murat Yasin and Soydaş, Şule Selin Akyan and Tabakçı, Satı Özkan and Bilgiç, Işıl and Çakar, Meltem Kürtül and Dinç, Gamze Akca and Ünlü, Ayyüce and Tokdemir, Bahar Ece and Yıldırım, Çelebi and Tuğcu, Gökçen Dilşa and Tural, Dilber Ademhan and Polat, Sanem Eryılmaz and Cinel, Güzin},
title = {Bronchoalveolar lavage: A key tool in pulmonary fungal infection management},
journal = {Turkish Journal of Pediatric Disease},
year = {2026},
pages = {1--5},
doi = {10.12956/tjpd.2026.1255}
}
EUVIMED